Search Results 461-470 of 12823 for hypercoagulable

  1. Deep vein thrombosis (DVT) - Doctors and departments - Mayo Clinic

    This potentially serious condition can occur with few or no symptoms. Know the risk factors.

  2. Publications - Julie A. Khoury, M.D. - Mayo Clinic

    Panrudkevich AH, Jones FJS, Shouman K, Klein CJ, Dyck PJB, Berini SE, Lamb CJ, Jacobi J, Staff NP, Dubey D, Engelstad JK, Martinez-Thompson JM, Grogan M, ...

  3. Publications - Andrea R. Huebner, Ph.D., L.P. - Mayo Clinic

    Gunderson J, Howie F, Mehta S, Redlin A, Huebner A. Sensitivity and Specificity Between the Screening Tool for Autism in Toddlers and Young Children (STAT) ...

  4. Study Of TBio-6517, Given Intratumorally, Alone Or In Combination With Pembrolizumab, In Solid Tumors - Mayo Clinic

    The purpose of this study is to determine the recommended Phase 2 dose (RP2D) of TBio-6517 when administered by direct injection into tumor(s) alone and when ...

  5. Deep vein thrombosis (DVT) - Doctors and departments - Mayo Clinic

    This potentially serious condition can occur with few or no symptoms. Know the risk factors.

  6. A Study to Evaluate the Pharmacokinetics of Low-Dose Bevacuzimab in Reducing Free Plasma VEGF-A in Hemodialysis Patients - Mayo Clinic

    Documented hypercoagulable state or history of 2 or more DVTs or other spontaneous intravascular thrombotic events; Bleeding diathesis; Anemia with a ...

  7. Teen suicide prevention - Mayo Clinic

    Male 3: I don't want you looking over my shoulder all the time. Female 3: But you know your kid better than anybody else and if you think he's acting different ...

  8. A Study Of Rivaroxaban (JNJ-39039039) On The Venous Thromboembolic Risk In Post-Hospital Discharge Patients - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of rivaroxaban compared with placebo in the prevention of symptomatic venous thromboembolism ( ...

  9. Deep vein thrombosis (DVT) - Doctors and departments - Mayo Clinic

    This potentially serious condition can occur with few or no symptoms. Know the risk factors.

  10. Device Evaluation for Point of Care Anticoagulation Testing - Mayo Clinic

    About this study. The purpose of this study is: To Evaluate and validate the Roche Coaguchek XS Plus analyzer at MCA to replace the ITC Hemochron Jr.